Dual-energy CT biomarkers for predicting the efficacy of TACE combined with lenvatinib and immune checkpoint inhibitors in unresectable HCC
Predicting response to TACE-LEN-ICIs in uHCC helps treatment decision-making. NIC-AP and PS from LD-DE&PCT, and tumor size were independent predictive biomarkers. NIC-AP was the best parameter for predicting response to TACE-LEN-ICIs in uHCC.
Authors
- Liqin Zhao (ORCID: https://orcid.org/0000-0002-1274-5179)
- K Zhang
- J H Zhang
- Mingzi Gao (ORCID: https://orcid.org/0009-0006-3777-9320)
- Mingxin Zhang (ORCID: https://orcid.org/0000-0002-8935-1194)
- Taoming Du
- Jing Han
- Yingxuan Wang
- Cheng Yan
- Yujie Chen
Institutions
- Capital Medical University (CN)
- Chengdu Medical College (CN)
- Beijing Tian Tan Hospital (CN)
- First Affiliated Hospital of Chengdu Medical College (CN)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- European Radiology Experimental
- Published
- 2026-01-19
- DOI
- https://doi.org/10.1186/s41747-025-00669-9
- Primary Topic
- Advanced X-ray and CT Imaging
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China